The Panama medicine deaths have reflected managerial differences between different countries, a senior official with China's drug watchdog said in Beijing on Monday.

"Management on imported drugs varies among different countries," said Wu Zhen, State Food and Drug Administration (SFDA) deputy director, at a press conference.

"This will inevitably result in blank points in management that may enable some companies to take advantage of the loophole," he said.
Discuss   Add this link to...  Bury

Comments Who Voted Related Links